Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: A nationwide study in Finland

Monitoring the performance of hip fracture treatment in Finland

(2011) Reijo Sund et al.   ANNALS OF MEDICINE

Dietary Calcium and Magnesium Intake and Mortality: A Prospective Study of Men

(2010) J. Kaluza et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and meta-analysis

(2010) Rohit Bhuriya et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral bisphosphonates are associated with reduced mortality after hip fracture

(2010) L. A. Beaupre et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D status and common risk factors for bone fragility as determinants of quantitative ultrasound variables in a nationally representative population sample

(2009) Maarit Kauppi et al.   BONE

Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy

(2009) Katerina Cermak et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Post-Fracture Prescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant Anti-Osteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture Patients

(2009) Ilona Nurmi-Lüthje et al.   DRUGS & AGING

Prescription of anti-osteoporosis drugs during 2004–2007—a nationwide register study in Norway

(2009) Helene M. Devold et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Potential mediators of the mortality reduction with zoledronic acid after hip fracture

(2009) Cathleen S Colón-Emeric et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prospective Study of Serum 25-Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-Cause Mortality in Older U.S. Adults

(2009) Adit A. Ginde et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Calcium Plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women's Health Initiative Calcium-Vitamin D Randomized Controlled Trial

(2009) A. Z. LaCroix et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Undertreatment of osteoporosis following hip fracture in the elderly

(2008) Peter Lüthje et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population

(2008) M. L. Melamed et al.   ARCHIVES OF INTERNAL MEDICINE

Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality

(2008) Harald Dobnig   ARCHIVES OF INTERNAL MEDICINE

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

(2008) René Rizzoli et al.   BONE

Vitamin D in the prevention and treatment of coronary heart disease

(2008) Armin Zittermann et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000

(2008) N. G. Forouhi et al.   DIABETES

Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture

(2008) Véronique Rabenda et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME